Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006254 · ClinicalTrials.gov registry record · Phase 1
VNP20009 in Treating Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by Vion Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00006254: Completed Phase 1 study, sponsored by Vion Pharmaceuticals.
NCT00006254 is a Phase 1 study that has completed, run by Vion Pharmaceuticals. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006254, a Phase 1 study, has completed, sponsored by Vion Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Biological therapies such as VNP20009 use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I trial to study the effectiveness of VNP20009 in treating patients who have advanced solid tumors.
Interventions
- BIOLOGICAL salmonella VNP20009
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-05 |
| Est. Completion | 2008-01 |
| Phase | Phase 1 |
What the finished NCT00006254 record still lists
NCT00006254 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which salmonella VNP20009 is the first listed.
NCT00006254 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006254 about?
NCT00006254 is a clinical study titled "VNP20009 in Treating Patients With Advanced Solid Tumors". RATIONALE: Biological therapies such as VNP20009 use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I trial to study the effectiveness of VNP20009 in treating patients who have advanced solid tumors.
What is the current status of trial NCT00006254?
This trial is currently completed. It is a Phase 1 study. The study started on 2000-05. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00006254?
The interventions under investigation include: salmonella VNP20009 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00006254?
This trial is sponsored by Vion Pharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia